Atlas Trials

Effects of S-1 and Capecitabine on Coronary Artery Blood Flow

Clinical trial NCT02216149 · TERMINATED

Trial details

NCT number
NCT02216149
Sponsor
Heikki Joensuu
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophagus CancerStomach CancerSmall Bowel CancerColon CancerRectum Cancer
Start date
2015-01-01
Primary completion
2018-08-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.